Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S March

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Abnormal Child Psychology|June 20, 1998
Racial differences on the Conners Teacher Rating ScaleJ N Epstein, J S March, C K Conners, et al.
Psychiatric Developments|January 1, 1989
Serotonin and treatment in obsessive-compulsive disorderJ S March, L D Gutzman, J W Jefferson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 1, 1997
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validityJ S March, J D Parker, K Sullivan, et al.
The Journal of Clinical Psychiatry|May 1, 1990
A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depressionJ S March, K A Kobak, J W Jefferson, et al.
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder?J S March, H Johnston, J W Jefferson, et al.
The Journal of Clinical Psychiatry|July 1, 1990
Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patientsJ H Greist, J W Jefferson, R Rosenfeld, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 9, 2001
Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorderE H Cook, K D Wagner, J S March, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 15, 2001
Sertraline in children and adolescents with social anxiety disorder: an open trialS N Compton, P J Grant, A K Chrisman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Anxiolytics, adrenergic agents, and naltrexoneM A Riddle, G A Bernstein, E H Cook, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Absence of cardiovascular adverse effects of sertraline in children and adolescentsT E Wilens, J Biederman, J S March, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Abnormal Child Psychology|June 20, 1998
Racial differences on the Conners Teacher Rating ScaleJ N Epstein, J S March, C K Conners, et al.
Psychiatric Developments|January 1, 1989
Serotonin and treatment in obsessive-compulsive disorderJ S March, L D Gutzman, J W Jefferson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 1, 1997
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validityJ S March, J D Parker, K Sullivan, et al.
The Journal of Clinical Psychiatry|May 1, 1990
A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depressionJ S March, K A Kobak, J W Jefferson, et al.
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder?J S March, H Johnston, J W Jefferson, et al.
The Journal of Clinical Psychiatry|July 1, 1990
Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patientsJ H Greist, J W Jefferson, R Rosenfeld, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 9, 2001
Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorderE H Cook, K D Wagner, J S March, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 15, 2001
Sertraline in children and adolescents with social anxiety disorder: an open trialS N Compton, P J Grant, A K Chrisman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Anxiolytics, adrenergic agents, and naltrexoneM A Riddle, G A Bernstein, E H Cook, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Absence of cardiovascular adverse effects of sertraline in children and adolescentsT E Wilens, J Biederman, J S March, et al.
Pageof 5